Possible progesterone-induced gestational activation of chromosomally integrated human herpesvirus 6B and transplacental transmission of activated human herpesvirus 6B

Journal of Heart and Lung Transplantation

Volumn 35, Issue 11, 2016, Pages 1373-1376

  Das, Bibhuti B ^a   Rakheja, Dinesh ^a   Lacelle, Chantale ^a   Sedlak, Ruth Hall ^b   Gulve, Nitish ^c   Chowdhury, Suvagata R ^c   Prusty, Bhupesh K ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ONDANSETRON; PROGESTERONE; SERTRALINE; VIRUS DNA;

ANTIBODY SPECIFICITY; AUTOPSY; CASE REPORT; CHROMOSOMALLY INTEGRATED HUMAN HERPESVIRUS 6B; CHROMOSOME; DEPRESSION; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ENDOCARDIAL FIBROELASTOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GESTATION PERIOD; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOFLUORESCENCE TEST; INFANT; LETTER; MALE; MATERNAL CARE; MEDICAL HISTORY; PERIPHERAL BLOOD MONONUCLEAR CELL; PLACENTA TISSUE; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPONTANEOUS ABORTION; TWIN PREGNANCY; VIRUS ACTIVATION; BLOOD; EXANTHEMA SUBITUM; FATALITY; FEMALE; GENETICS; GESTATIONAL AGE; METABOLISM; NEWBORN; PREGNANCY; TRANSMISSION; VERTICAL TRANSMISSION; VIROLOGY;

DNA, VIRAL; FATAL OUTCOME; FEMALE; GESTATIONAL AGE; HERPESVIRUS 6, HUMAN; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; POLYMERASE CHAIN REACTION; PREGNANCY; PROGESTERONE; ROSEOLOVIRUS INFECTIONS;

EID: 84994434535     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2016.08.009     Document Type: Letter

References (7)

1. 1 Kaufer, B.B., Flamand, L., Chromosomally integrated HHV-6: impact on virus, cell and organismal biology. Curr Opin Virol 9C (2014), 111–118.
2. 2 Arbuckle, J.H., Medveczky, M.M., Luka, J., et al. The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosome in vivo and in vitro. Proc Natl Acad Sci U S A 107 (2010), 5563–5568.
3. 3 Ishida, T., Kano, Y., Mizukawa, Y., et al. The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome. Allergy 69 (2014), 798–805.
4. 4 Ward, K.N., Leong, H.N., Nacheva, E.P., et al. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol 44 (2006), 1571–1574.
5. 5 Tohyama, M.I., Hashomoto, K., Yasukawa, M., et al. Association of human herpesvirus 6 reactivation with flaring and severity of drug induced hypersensitivity syndrome. Br J Dermatol 157 (2007), 934–940.
6. 6 Drago, F., Broccolo, F., Zaccaria, E., et al. Pregnancy outcome in patients with pityriasis rosea. J Am Acad Dermatol 58 (2008), S78–S83.
7. 7 Kuhl, U., Pauschinger, M., Seeberg, B., et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 46 (2005), 1245–1256.